|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J,
Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin.
58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RI, De Santis C, Virgo K, Stein K,
Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, et al:
Cancer treatment and survivorship statistics, 2012. CA Cancer J
Clin. 62:220–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kandoth C, Schultz N, Cherniack AD, Akbani
R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, et al:
Cancer Genome Atlas Research Network: Integrated genomic
characterization of endometrial carcinoma. Nature. 497:67–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Risinger JI, Hayes AK, Berchuck A and
Barrett JC: PTEN/MMAC1 mutations in endometrial cancers. Cancer
Res. 57:4736–4738. 1997.PubMed/NCBI
|
|
6
|
Oda K, Stokoe D, Taketani Y and McCormick
F: High frequency of coexistent mutations of PIK3CA and PTEN genes
in endometrial carcinoma. Cancer Res. 65:10669–10673. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shoji K, Oda K, Nakagawa S, Hosokawa S,
Nagae G, Uehara Y, Sone K, Miyamoto Y, Hiraike H, Hiraike-Wada O,
et al: The oncogenic mutation in the pleckstrin homology domain of
AKT1 in endometrial carcinomas. Br J Cancer. 101:145–148. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Urick ME, Rudd ML, Godwin AK, Sgroi D,
Merino M and Bell DW: PIK3R1 (p85α) is somatically mutated at high
frequency in primary endometrial cancer. Cancer Res. 71:4061–4067.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rudd ML, Price JC, Fogoros S, Godwin AK,
Sgroi DC, Merino MJ and Bell DW: A unique spectrum of somatic
PIK3CA (p110α) mutations within primary endometrial carcinomas.
Clin Cancer Res. 17:1331–1340. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cheung LW, Hennessy BT, Li J, Yu S, Myers
AP, Djordjevic B, Lu Y, Stemke-Hale K, Dyer MD, Zhang F, et al:
High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer
elucidates a novel mechanism for regulation of PTEN protein
stability. Cancer Discov. 1:170–185. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang H, Cheung LW, Li J, Ju Z, Yu S,
Stemke-Hale K, Dogruluk T, Lu Y, Liu X, Gu C, et al: Whole-exome
sequencing combined with functional genomics reveals novel
candidate driver cancer genes in endometrial cancer. Genome Res.
22:2120–2129. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Edge S, Byrd D, Compton C, et al: AJCC
Cancer Staging. Manual (7th). (New York, NY). Springer. 2010.
|
|
13
|
Silverberg SG, Kurman RJ, Nogales F, et
al: Tumors of the uterine corpus: Epithelial tumours and related
conditions. Tumors of the Breast and Gynecologic Tract. Tavassoli
FA and Devilee PL: (Lyon). IARC Press. 2182002.
|
|
14
|
Burke JE, Perisic O, Masson GR, Vadas O
and Williams RL: Oncogenic mutations mimic and enhance dynamic
events in the natural activation of phosphoinositide 3-kinase p110α
(PIK3CA). Proc Natl Acad Sci USA. 109:15259–15264. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gymnopoulos M, Elsliger MA and Vogt PK:
Rare cancer-specific mutations in PIK3CA show gain of function.
Proc Natl Acad Sci USA. 104:5569–5574. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Rios JJ, Paria N, Burns DK, Israel BA,
Cornelia R, Wise CA and Ezaki M: Somatic gain-of-function mutations
in PIK3CA in patients with macrodactyly. Hum Mol Genet. 22:444–451.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao J, Aksoy BA, Dogrusoz U, Dresdner G,
Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, et al:
Integrative analysis of complex cancer genomics and clinical
profiles using the cBioPortal. Sci Signal. 6:112013.
|
|
19
|
Liao X, Morikawa T, Lochhead P, Imamura Y,
Kuchiba A, Yamauchi M, Nosho K, Qian ZR, Nishihara R, Meyerhardt
JA, et al: Prognostic role of PIK3CA mutation in colorectal cancer:
Cohort study and literature review. Clin Cancer Res. 18:2257–2268.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang L, Shi L, Zhao X, Wang Y and Yue W:
PIK3CA gene mutation associated with poor prognosis of lung
adenocarcinoma. Onco Targets Ther. 6:497–502. 2013.PubMed/NCBI
|
|
21
|
Kalinsky K, Jacks LM, Heguy A, Patil S,
Drobnjak M, Bhanot UK, Hedvat CV, Traina TA, Solit D, Gerald W, et
al: PIK3CA mutation associates with improved outcome in breast
cancer. Clin Cancer Res. 15:5049–5059. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shigaki H, Baba Y, Watanabe M, Murata A,
Ishimoto T, Iwatsuki M, Iwagami S, Nosho K and Baba H: PIK3CA
mutation is associated with a favorable prognosis among patients
with curatively resected esophageal squamous cell carcinoma. Clin
Cancer Res. 19:2451–2459. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McIntyre JB, Nelson GS, Ghatage P, Morris
D, Duggan MA, Lee CH, Doll CM and Köbel M: PIK3CA missense mutation
is associated with unfavorable outcome in grade 3 endometrioid
carcinoma but not in serous endometrial carcinoma. Gynecol Oncol.
132:188–193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Catasus L, Gallardo A, Cuatrecasas M and
Prat J: PIK3CA mutations in the kinase domain (exon 20) of uterine
endometrial adenocarcinomas are associated with adverse prognostic
parameters. Mod Pathol. 21:131–139. 2008.PubMed/NCBI
|
|
25
|
Dong Y, Yang X, Wong O, Zhang X, Liang Y,
Zhang Y, Wong W, Nong L, Liao Q and Li T: PIK3CA mutations in
endometrial carcinomas in Chinese women: Phosphatidylinositol
3-kinase pathway alterations might be associated with favorable
prognosis. Hum Pathol. 43:1197–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
